Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Marek Trneny

Rituximab Maintenance Therapy After Autologous Stem-Cell Transplantation in Patients With Relapsed CD20+Diffuse Large B-Cell Lymphoma: Final Analysis of the Collaborative Trial in Relapsed Aggressive Lymphoma

Journal of Clinical Oncology

English

Prognostic Impact of Somatic Mutations in Diffuse Large B-Cell Lymphoma and Relationship to Cell-Of-Origin: Data From the Phase III GOYA Study

Haematologica

Hematology

2019

English

Related publications

Characteristics and Outcomes of Relapsed Follicular Lymphoma After Autologous Stem Cell Transplantation in the Rituximab Era

Hematological Oncology

English

Bendamustine Combined With Rituximab for Patients With Relapsed or Refractory Diffuse Large B Cell Lymphoma

English

Rituximab and Autologous Stem-Cell Transplantation for High-Risk Diffuse Large B-Cell Lymphoma – Authors' Reply

The Lancet Oncology

Oncology

2017

English

Rituximab, Bendamustine and Cytarabine (R-Bac) in Patients With Relapsed-Refractory Aggressive B-Cell Lymphoma

American Journal of Hematology

Hematology

2018

English

Outcomes of Autologous Stem Cell Transplantation (ASCT) in Patients With Relapsed/Refractory HIV-associated Lymphoma

Bone Marrow Transplantation

Transplantation

Hematology

2016

English

Direct Costs Associated With Relapsed Diffuse Large B‐Cell Lymphoma Therapies

English

Intravenous Immunoglobulin Therapy Use in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma Treated With Tisagenlecleucel in the Juliet Trial

Hematological Oncology

English

Autologous Stem Cell Transplantation for Diffuse Large B-Cell Lymphoma With Residual Extranodal Involvement

Korean Journal of Internal Medicine

Internal Medicine

2008

English

Long-Term Efficacy and Safety of Lenalidomide Maintenance in Patients With Relapsed Diffuse Large B-Cell Lymphoma Who Are Not Eligible for Autologous Transplantation (Asct)

Hematological Oncology

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Marek Trneny

Rituximab Maintenance Therapy After Autologous Stem-Cell Transplantation in Patients With Relapsed CD20+Diffuse Large B-Cell Lymphoma: Final Analysis of the Collaborative Trial in Relapsed Aggressive Lymphoma

Prognostic Impact of Somatic Mutations in Diffuse Large B-Cell Lymphoma and Relationship to Cell-Of-Origin: Data From the Phase III GOYA Study

Related publications

Characteristics and Outcomes of Relapsed Follicular Lymphoma After Autologous Stem Cell Transplantation in the Rituximab Era

Bendamustine Combined With Rituximab for Patients With Relapsed or Refractory Diffuse Large B Cell Lymphoma

Rituximab and Autologous Stem-Cell Transplantation for High-Risk Diffuse Large B-Cell Lymphoma – Authors' Reply

Rituximab, Bendamustine and Cytarabine (R-Bac) in Patients With Relapsed-Refractory Aggressive B-Cell Lymphoma

Outcomes of Autologous Stem Cell Transplantation (ASCT) in Patients With Relapsed/Refractory HIV-associated Lymphoma

Direct Costs Associated With Relapsed Diffuse Large B‐Cell Lymphoma Therapies

Intravenous Immunoglobulin Therapy Use in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma Treated With Tisagenlecleucel in the Juliet Trial

Autologous Stem Cell Transplantation for Diffuse Large B-Cell Lymphoma With Residual Extranodal Involvement

Long-Term Efficacy and Safety of Lenalidomide Maintenance in Patients With Relapsed Diffuse Large B-Cell Lymphoma Who Are Not Eligible for Autologous Transplantation (Asct)